Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.14.99.3 (
heme oxygenase
)
4,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bile acids have been implicated in cholestatic liver damage, primarily due to their detergent effect on membranes and induction of oxidative stress. Gangliosides can counteract these harmful effects by increasing the rigidity of the cytoplasmic membrane. Induction of
haem oxygenase
(
HMOX
) has been shown to protect the liver from increased oxidative stress. The aim of this study was to determine the changes in the synthesis and distribution of liver gangliosides following bile duct ligation (BDL), and to assess the effects of
HMOX
both on cholestatic liver injury and ganglioside metabolism. Compared to controls, BDL resulted in a significant increase in total as well as complex gangliosides and mRNA expression of corresponding glycosyltransferases ST3GalV,
ST8SiaI
and B3GalTIV. A marked shift of GM1 ganglioside from the intracellular compartment to the cytoplasmic membrane was observed following BDL. Induction of oxidative stress by
HMOX
inhibition resulted in a further increase of these changes, while
HMOX
induction prevented this effect. Compared to BDL alone,
HMOX
inhibition in combination with BDL significantly increased the amount of bile infarcts, while
HMOX
activation decreased ductular proliferation. We have demonstrated that cholestasis is accompanied by significant changes in the distribution and synthesis of liver gangliosides.
HMOX
induction results in attenuation of the cholestatic pattern of liver gangliosides, while
HMOX
inhibition leads to the opposite effect.
...
PMID:Changes in Liver Ganglioside Metabolism in Obstructive Cholestasis - the Role of Oxidative Stress. 2764 80